Nuclear overexpression levels of MAGE‐A3 predict poor prognosis in patients with prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nuclear overexpression levels of MAGE‐A3 predict poor prognosis in patients with prostate cancer

Published:2021-04-13 Issue:6 Volume:129 Page:291-303
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:APMIS

Author:

khalvandi Azadeh¹,Abolhasani Maryam²³,Madjd Zahra³,Shekarabi Mehdi¹,Kourosh‐Arami Masoumeh⁴,Mohsenzadegan Monireh⁵

Affiliation:

1. Department of Immunology School of Medicine Iran University of Medical Sciences Tehran Iran

2. Hasheminejad Kidney Center Iran University of Medical Sciences Tehran Iran

3. Oncopathology Research Center Iran University of Medical Sciences Tehran Iran

4. Department of Neuroscience School of Advanced Technologies in Medicine Iran University of Medical Sciences Tehran Iran

5. Department of Medical Laboratory Science Faculty of Allied Medical Sciences Iran University of Medical Sciences Tehran Iran

Funder

Iran University of Medical Sciences

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apm.13132

Reference44 articles.

1. The role of JNK in prostate cancer progression and therapeutic strategies

2. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates

3. Immunotherapy for Prostate Cancer

4. Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks

5. The MAGE protein family and cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DUB3 is a MAGEA3 deubiquitinase and a potential therapeutic target in hepatocellular carcinoma;iScience;2024-03

2. MAGE-A3 regulates tumor stemness in gastric cancer through the PI3K/AKT pathway;Aging;2022-11-08

3. Cancer germline antigens and tumor-agnostic CD8+ T cell evasion;Trends in Immunology;2022-05

4. Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer;Scientific Reports;2022-01-12

5. MicroRNA-119 Inhibitor-Loaded Nanoparticles Improve Non-Small Cell Lung Cancer and Suppress Metastasis Through Up-Regulation of Autophagy-Related Proteins;Science of Advanced Materials;2021-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3